data in brief_γ-Tocotrienol Inhibits Cervical Cancer HeLa Cells Growth through Regulating the PI3K/AKT/mTOR Signaling Pathway

Published: 1 November 2024| Version 1 | DOI: 10.17632/rg8y7pyyzz.1
Contributor:
weili xu

Description

The file is a Data in Brief used by Xu et al study forγ-Tocotrienol Inhibits Cervical Cancer HeLa Cells Growth through Regulating the PI3K/AKT/mTOR Signaling Pathway in vitro. The data showed that γ-T3 (30-60 μM, especially at 45 μM) treatment significantly inhibited HeLa cellular proliferation, and its IC50 was 37.40 ± 5.70 µM at 48 hours. It induced apoptosis and increased the proportion of cells in G0/G1 phase and decreased the proportion at S phase in HeLa cells. The treatment decreased the levels of both phosphorylated and non-phosphorylated (+/-p) mTOR, upstream regulatory factors of PI3K, (+/-p) AKT, downstream regulatory factors of (+/-p) p70S6K, (+/-p) 4E-BP1 and targeted genes of Cyclin D1 and c-Myc related to HeLa cell proliferation and apoptosis. These effects of γ-T3 on the HeLa cells were similar to the actions of Wortmannin (WM), a known blocker of the PI3K/AKT/mTOR signaling pathway. Furthermore, the combination of γ-T3 and WM displayed a strong synergistic effect. These results suggest that γ-T3 could inhibit cell growth by down-regulating the PI3K/AKT/mTOR signaling pathway in human cervical cancer HeLa cells.

Files

Institutions

Harbin Institute of Technology

Categories

Database

Funding

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

31501481

National Key Research and Development Program of China

2021YFD2100902

Licence